[44] first suggested that CREB1 is a downstream effector of miR‐450a mediating growth and metastatic traits in breast cancer cells, and that elevated CREB1 expression is associated with poor ER+ breast cancer prognosis. Here, CREB1 is linked to breast carcinoma.